Autifony Therapeutics Limited
PrivateLast Round
Grant
Mar 15, 2017
Total Funding Raised
$43.01M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Autifony Therapeutics Limited is a biotechnology company that develops novel medicines to treat rare genetic CNS disorders by using its ion channel drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autifony Therapeutics Limited Comparables
Compare Autifony Therapeutics Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kaerus Bioscience | 81% | |
| Connecta Therapeutics | 80% | |
| Shionogi & Co. | 78% | |
Autifony Therapeutics Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 15, 2017 | ||||
| Series A Extension | Jul 10, 2015 | ||||
| Grant | Mar 1, 2014 | ||||
| Series A Extension | Jun 4, 2013 | ||||
| Series A | Aug 22, 2011 |
Key People
Founding team and executive leadership
Autifony Therapeutics Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A Extension, Series A |
| Innovate UK | Grant |
| Imperial Innovations | Series A |
| Medical Research Council | Grant |
| UCL Business | Series A Extension |
| Pfizer Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 332% MoM, reaching 2.3K.
- Apr 17, 2026
Monthly visitors increased 30% MoM.
Autifony Therapeutics Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Autifony Therapeutics Limited's valuation, stock price, and market status.